 Connection
Laurel Beaty to Adult
This is a "connection" page, showing publications Laurel Beaty has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.162 |
|
|
|
-
Trent SA, Beaty L, Peers J, Simon S, Scovorodniev A, Kireeva I, Fishchuk R, Carlson NE, Ginde AA, Bills CB. Clinical epidemiology, microbiology, and care of war-related wounds in Ukraine. J Trauma Acute Care Surg. 2026 Aug 01; 101(2 Suppl 2026):S137-S142.
Score: 0.011
-
Douin DJ, Rice JD, Xiao M, Beaty L, Guo C, Withers C, Sullivan A, Anderson EL, Cheng AC, Banasiewicz MK, Semler MW, Lloyd BD, Maiga A, Gibbs KW, Stettler GR, Khan A, Sally MB, Wright FL, Aggarwal N, Bebarta VS, Ginde AA. Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol. BMJ Open. 2026 Jan 28; 16(1):e110739.
Score: 0.011
-
Agarwal T, Beaty LE, Carlson NE, Bennett TD, Fish LE, Mayer DA, Molina KC, Peers JL, Webb BJ, Xiao M, Ginde AA, Aggarwal NR. Association of remdesivir treatment with long-term mortality after COVID-19 hospitalization. BMC Infect Dis. 2025 Oct 28; 25(1):1418.
Score: 0.011
-
Friedman JC, Hutchens K, Starkman H, Beaty LE, Sammel MD, Finn E, Appiah LC, Alaniz VI, Chan CL. Sex Hormone Replacement Therapy and Bleeding Patterns among Adolescents and Young Adult Females with Prader-Willi Syndrome. J Pediatr Adolesc Gynecol. 2025 Dec; 38(6):724-730.
Score: 0.011
-
Douin DJ, Rice JD, Xiao M, Jackson CL, Anderson EL, Cheng AC, Cwik J, Beaty LE, Wild JL, Beyene RT, Britton GW, Corcos AC, Dale EL, Hwang J, Jansen JO, Self WH, Slater JC, Steinwand A, Wiktor AJ, Ziembicki J, Schauer SG, Bebarta VS, Cancio L, Ginde AA. Effect of targeting normoxemia on supplemental oxygen-free days for adults with acute thermal burns: A stepped wedge cluster randomized clinical trial. J Trauma Acute Care Surg. 2025 10 01; 99(4):619-627.
Score: 0.011
-
Rosenberg S, Hutchens K, Roth LP, Beaty L, Vemulakonda VM, Alaniz VI. Screening Practices for Müllerian Anomalies in Patients With Known Renal or Urologic Anomalies: A Retrospective Chart Review. J Pediatr Surg. 2025 Sep; 60(9):162393.
Score: 0.011
-
Douin DJ, Rice JD, Anderson EL, Jackson CL, Cheng AC, Xiao M, Cwik J, Beaty LE, Wild JL, Daya MR, Doshi PB, Eastham SC, Goodman MD, Gunn SR, Haukoos JS, Hudson JA, Jansen JO, McMullan JT, Rizzo JA, Schreiber MA, Self WH, Semler MW, Steinwand A, Werner N, Bebarta VS, Schauer SG, Ginde AA. Targeted Normoxemia and Supplemental Oxygen-Free Days in Critically Injured Adults: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Netw Open. 2025 03 03; 8(3):e252093.
Score: 0.011
-
Xiao M, Molina KC, Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Fish LE, Hamer MK, Kwan BM, Mayer DA, Peers JL, Wynia MK, Ginde AA. A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies. JAMA Health Forum. 2024 09 06; 5(9):e242884.
Score: 0.010
-
Molina KC, Webb BJ, Kennerley V, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Aggarwal NR, Ginde AA. Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5. BMC Infect Dis. 2024 Aug 08; 24(1):802.
Score: 0.010
-
Roberts SC, Jolley SE, Beaty LE, Aggarwal NR, Bennett TD, Carlson NE, Fish LE, Kwan BM, Russell S, Wogu AF, Wynia MA, Ginde AA. Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19. J Med Virol. 2024 03; 96(3):e29541.
Score: 0.010
-
Vemuru SR, Bronsert M, Vossler K, Huynh VD, Beaty L, Ahrendt G, Arruda J, Kaoutzanis C, Rojas KE, Bozzuto L, Kim S, Tevis SE. Postoperative Outcomes After Staged Versus Coordinated Breast Surgery and Bilateral Salpingo-Oophorectomy. Ann Surg Oncol. 2023 Sep; 30(9):5667-5680.
Score: 0.009
-
Molina KC, Kennerley V, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Aggarwal NR, Ginde AA. Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5. Int J Infect Dis. 2023 Jul; 132:34-39.
Score: 0.009
-
Aggarwal NR, Molina KC, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Ginde AA. Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study. Lancet Infect Dis. 2023 06; 23(6):696-705.
Score: 0.009
-
Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Davis CB, Kwan BM, Mayer DA, Ong TC, Russell S, Steele J, Wogu AF, Wynia MK, Zane RD, Ginde AA. Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. J Infect Dis. 2022 12 13; 226(12):2129-2136.
Score: 0.009
-
Wynia MK, Beaty LE, Bennett TD, Carlson NE, Davis CB, Kwan BM, Mayer DA, Ong TC, Russell S, Steele JD, Stocker HR, Wogu AF, Zane RD, Sokol RJ, Ginde AA. Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients. Chest. 2023 05; 163(5):1061-1070.
Score: 0.009
-
Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Molina KC, Peers JL, Russell S, Wynia MK, Ginde AA. Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase. Int J Infect Dis. 2023 Mar; 128:310-317.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|